MedTrace Logo

Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows

NCT01891487 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2015-01-14

No results posted yet for this study

Summary

This is a study researching the safety and efficacy of Bimatoprost 0.03% soultion versus placebo applied to the eyebrow for the treatment of thinning eyebrows. This is a 36 week study where Bimatoprost 0.03% solution/placebo will be applied once daily to the subjects eyebrow for duration of the study.

Conditions

  • Hypotrichosis

Interventions

DRUG

Track A

Bimatoprost 0.03% solution applied to eyebrow

DRUG

Track B

Refresh Tears applied to eyebrows

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • ATS Clinical Research

    lead OTHER

Principal Investigators

  • Ava Shamban, MD · ATS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-09-30
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891487 on ClinicalTrials.gov